Endometrium Cancer Clinical Trials

7 recruiting

Frequently Asked Questions

Common questions about Endometrium Cancer clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

Comparative Study on the Effect of Diet Interventions on Weight Loss in Overweight Endometrial Cancer Patients Undergoing Fertility-sparing Treatment

Endometrium Cancer
Peking University People's Hospital81 enrolled1 locationNCT07318727
Recruiting
Phase 1Phase 2

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

Triple-Negative Breast CancerAdvanced Solid TumorHead and Neck Squamous Cell Carcinoma+7 more
Volastra Therapeutics, Inc.200 enrolled14 locationsNCT05902988
Recruiting
Not Applicable

Weight Management in Overweight Endometrial Cancer Patients Undergoing Fertility-sparing Treatment

Endometrium Cancer
Peking University People's Hospital240 enrolled1 locationNCT06169449
Recruiting

A.I and Machine Learning Based Risk Prediction Model to Improve the Clinical Management of Endometrial Cancer.

Endometrium Cancer
Regina Elena Cancer Institute40 enrolled1 locationNCT06841653
Recruiting

Stratifying Endometrial Cancer Patients Using a PET/MRI Prognostic Model

Endometrium Cancer
IRCCS San Raffaele101 enrolled1 locationNCT04212910
Recruiting
Phase 1Phase 2

Pembrolizumab With Ataluren in Patients With Metastatic pMMR and dMMR Colorectal Carcinoma or Metastatic dMMR Endometrial Carcinoma: the ATAPEMBRO Study

Colorectal, CancerEndometrium Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)47 enrolled1 locationNCT04014530
Recruiting
Not Applicable

Predictive Clinical and Biological Parameters in Gynecological Cancer

Ovarian CancerCervix CancerEndometrium Cancer
Institut Paoli-Calmettes300 enrolled1 locationNCT01977274